Stay updated on Nivolumab and Ipilimumab in ACC Clinical Trial

Sign up to get notified when there's something new on the Nivolumab and Ipilimumab in ACC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab and Ipilimumab in ACC Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page revision was updated from v3.5.3 to v3.5.4, indicating a small version update with no visible changes to the study details.
    Difference
    0.0%
    Check dated 2026-05-14T23:08:16.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.2 to v3.5.3, signaling an updated version of the page's documentation or template. The change does not modify any study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-04-30T16:51:12.000Z thumbnail image
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.5.2 has been added and Revision: v3.5.0 has been removed. This update is a metadata/version tag for the site and does not alter study content or user interactions.
    Difference
    0.0%
    Check dated 2026-04-16T10:49:23.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Added Revision: v3.5.0; Removed Revision: v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-18T17:51:04.000Z thumbnail image
  7. Check
    74 days ago
    Change Detected
    Summary
    - Footer revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-11T16:51:29.000Z thumbnail image
  8. Check
    103 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2 and removed the funding-lapse notice (previous Revision: v3.4.1).
    Difference
    0.4%
    Check dated 2026-02-11T02:16:41.000Z thumbnail image

Stay in the know with updates to Nivolumab and Ipilimumab in ACC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab and Ipilimumab in ACC Clinical Trial page.